SAN DIEGO, Feb. 6, 2018 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that both the Company and its subsidiary Kannaway® generated the largest-ever (unaudited) revenue month in its history in January of 2018, as well as reached major milestones in its business operations.
“In 2017, we had the best year in the history of our Company in terms of product sales and overall revenues; we are working on audits and financials for future reporting. 2018 is off to a great start and with many events scheduled in the US as well as internationally,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “Also, there is a good deal of growth happening throughout the entire cannabis industry and our Company plans to utilize that growth to continue our expansion into new markets.”
Medical Marijuana, Inc. experienced many accomplishments in January including launching its newest subsidiary Phyto Animal Health and obtaining positive news coverage in several national and international publications including TMZ Entertainment, FOXNews.com and Hemp Magazine.
“Kannaway has grown exponentially since its relaunch in March of 2016, and is now focused on both domestic and international growth,” said Kannaway CEO Blake Schroeder. “We are confident that 2018 will be a year of even more record-breaking milestones and achievements.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.